Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro

J Antimicrob Chemother. 2003 Jun;51(6):1327-30. doi: 10.1093/jac/dkg240. Epub 2003 Apr 25.

Authors

Beatrice Macchi¹, Emanuela Balestrieri, Antonio Mastino

Affiliation

¹ Department of Neuroscience, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy. [email protected]

PMID: 12716774
DOI: 10.1093/jac/dkg240

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Anti-Retroviral Agents / pharmacology
Anti-Retroviral Agents / therapeutic use*
HTLV-I Infections / drug therapy*
Human T-lymphotropic virus 1 / drug effects*
Human T-lymphotropic virus 1 / growth & development
Humans
Lamivudine / pharmacology
Lamivudine / therapeutic use
Nucleosides / pharmacology
Nucleosides / therapeutic use*
Zidovudine / pharmacology
Zidovudine / therapeutic use

Substances

Anti-Retroviral Agents
Nucleosides
Lamivudine
Zidovudine